About TRIO - Translational Research in Oncology-US, Inc.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at TRIO - Translational Research in Oncology-US, Inc.
During the past decade, TRIO - Translational Research in Oncology-US, Inc. conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 6 clinical trials were completed, i.e. on
average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "TRIO - Translational Research in Oncology-US, Inc."
#1 collaborator was "ARMO BioSciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at TRIO - Translational Research in Oncology-US, Inc.
According to Clinical.Site data, the most researched conditions in "TRIO - Translational Research in Oncology-US, Inc." are
"Breast Neoplasms" (2 trials), "Neoplasm Metastasis" (2 trials), "Abiraterone Acetate" (1 trials), "Androgens" (1 trials) and "Antineoplastic Agents" (1 trials). Many other conditions were trialed in "TRIO - Translational Research in Oncology-US, Inc." in a lesser frequency.
Clinical Trials Intervention Types at TRIO - Translational Research in Oncology-US, Inc.
Most popular intervention types in "TRIO - Translational Research in Oncology-US, Inc." are "Drug" (11 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Abemaciclib" (7 trials), "Placebo" (6 trials), "Fulvestrant" (3 trials), "Anastrozole" (2 trials) and "Letrozole" (2 trials). Other intervention names were less common.
Clinical Trials Genders at TRIO - Translational Research in Oncology-US, Inc.
The vast majority of trials in "TRIO - Translational Research in Oncology-US, Inc." are
6 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at TRIO - Translational Research in Oncology-US, Inc.
Currently, there are NaN active trials in "TRIO - Translational Research in Oncology-US, Inc.".
undefined are not yet recruiting,
4 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in TRIO - Translational Research in Oncology-US, Inc.,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in TRIO - Translational Research in Oncology-US, Inc., 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of TRIO - Translational Research in Oncology-US, Inc.
TRIO - Translational Research in Oncology-US, Inc. has several departments that took part in Clinical trials: "TRIO - Comprehensive Cancer Centers of Nevada" - 2 trials